Leading science, pioneering therapies

CRM Publications

Found 2 results
Filters: Keyword is Risk Assessment  [Clear All Filters]
2011
Connick P, Kolappan M, Patani R, Scott MA, Crawley C, He X-L, Richardson K, Barber K, Webber DJ, Wheeler-Kingshott CAM et al..  2011.  The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessments.Trials. 12:62.
2010
Fox KAA, Carruthers KF, Dunbar DR, Graham C, Manning JR, De Raedt H, Buysschaert I, Lambrechts D, Van de Werf F.  2010.  Underestimated and under-recognized: the late consequences of acute coronary syndrome (GRACE UK-Belgian Study).Eur Heart J. 31(22):2755-64.